Sriram Deivasigamani

Sriram Deivasigamani


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in European Urology
Verified
Journal Article
Closed access
SDSriram Deivasigamani
Sriram Deivasigamani
SKSrinath Kotamarti
Srinath Kotamarti
ARArdeshir R. Rastinehad
Ardeshir R. Rastinehad
RSRafael Sanchez Salas
Rafael Sanchez Salas
JRJ.J.M.C.H. de la Rosette
J.J.M.C.H. de la Rosette
TPThomas J. Polascik
Thomas J. Polascik

25 November 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
SDSriram Deivasigamani
Sriram Deivasigamani
EAEric S. Adams
Eric S. Adams
SKSrinath Kotamarti
Srinath Kotamarti
Mahdi MottaghiMahdi Mottaghi
Mahdi Mottaghi
TTTerek Taha
Terek Taha
TPThomas J. Polascik
Thomas J. Polascik

18 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
EAEric Sharold Adams
Eric Sharold Adams
SDSriram Deivasigamani
Sriram Deivasigamani
Mahdi MottaghiMahdi Mottaghi
Mahdi Mottaghi
JHJiaoti Huang
Jiaoti Huang
RGRajan T. Gupta
Rajan T. Gupta
TPThomas J. Polascik
Thomas J. Polascik
Recurrent prostate cancer after primary treatment with radiation therapy is a common problem. Patients with localized recurrence may benefit from salvage therapy, but careful patient selection is crucial because not all patients will benefit from local salvage therapy, and salvage therapy has increased morbidity compared to primary treatments for prostate cancer. This review aims to provide an overview of the evaluation of patients with recurrent disease after radiation therapy and how it is continuing to evolve with increasing data on outcomes, as well as improving technologies and techniques. Our enhanced understanding of treatment outcomes and risk stratification has influenced the identification of patients who may benefit from local salvage treatment. Advances in imaging and biopsy techniques have enhanced the accuracy of locating the recurrence, which affects treatment decisions. Additionally, the growing interest in image-targeted ablative therapies that have less morbidity and complications than whole-gland therapies for suitable patients influences the evaluation process for those considering focal salvage therapy. Although significant changes have been made in the diagnostic evaluation of patients with recurrent disease after radiation therapy, it remains unclear whether these changes will ultimately improve patient outcomes.


28 June 2023 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
SCScott P. Campbell
Scott P. Campbell
SDSriram Deivasigamani
Sriram Deivasigamani
RARohith Arcot
Rohith Arcot
EAEric S. Adams
Eric S. Adams
HOHazem Orabi
Hazem Orabi
TPThomas J. Polascik
Thomas J. Polascik

10 February 2021 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
SDSriram Deivasigamani
Sriram Deivasigamani
SISanthosh Irrinki
Santhosh Irrinki
JSJimil Shah
Jimil Shah
YSYashwant Sakaray
Yashwant Sakaray
Cocaine, an alkaloid, is an addictive drug and its abuse as a recreational drug is on the increasing side with its associated complications. Gastrointestinal complications, after cocaine abuse, are less known and need to be addressed since the abuse is on the rise and the existing evidence is scarce. We report a case of a 22-year-old male patient who presented with abdominal pain following a cocaine injection. On examination, signs of peritonitis were noted and laparotomy revealed a 2×1 cm perforation in the distal ileum. The unhealthy intestinal segment was resected and taken out as a double-barrel ileostomy. The patient had an episode of severe lower gastrointestinal bleeding on postoperative day 6. CT and colonoscopy revealed signs of ischaemic bowel and tissue biopsy showed oedematous, inflamed and haemorrhagic bowel mucosa. The patient was managed conservatively and is doing well under follow-up in a de-addiction centre.